Research Article
Are Thyroid Hormone and Tumor Cell Proliferation in Human Breast Cancers Positive for HER2 Associated?
Table 2
Comparison of clinical and histopathological characteristics in HER2(+) and HER2(−) breast cancer patients.
| | HER2 staining | Significance | | Negative () | Positive () |
| Age (years) | 60.3 (1.6) | 60.1 (3.3) | = 0.95 | Tumor size (cm) | 2.3 (0.12) | 3.0 (0.28) | | Ki67 | 8 (0.9) | 16 (2.3) | | Menopause | | | | No | 29.7% | 27.3% | = 0.83 | Yes | 70.3% | 72.7% | Clinical stage | | | | I | 28.1% | 13.6% | = 0.40 | II | 53.1% | 54.5% | III | 12.5% | 18.2% | IV | 6.3% | 13.6% | Histopathological grade | | | | 1 | 9.8% | 4.5% | = 0.63 | 2 | 77% | 86.4% | 3 | 13.2% | 9.1% | PR staining | | | | Negative | 28.6% | 33.3% | = 0.68 | Positive | 71.4% | 66.7% |
|
|